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The Global Forum for Health Research, an independent international foundation housed at World 
Health Organization (WHO) headquarters in Geneva, is forging partnerships with public and 
private sector agencies to focus health research spending on the world's most devastating diseases.  
The Forum, which began operating in January 1998, was launched to help correct the "10/90 gap" 
in health research — a problem identified in 1990 by the Commission on Health Research for 
Development, the World Bank's 1993 World Development Report, Investing in Health, and the 
1996 Report of the Ad Hoc Committee on Health Research. The Forum receives funding from the 
World Bank, WHO, the Rockefeller Foundation, and other organizations including the 
International Development Research Centre (IDRC).  
10/90 gap  
At least US$70 billion is spent annually on global health research by public and private sectors. 
But less than 10% of this amount is devoted to addressing 90% of the total global disease burden, 
says Louis Currat, Executive Secretary of the Global Forum for Health Research. This 
misallocation of global health research spending has been dubbed the "10/90 gap."  
Using the Disability-Adjusted Life Year (DALY) measure — an indicator that reflects the total 
amount of healthy life lost due to premature mortality, disability, and other causes — an estimated 
40% of the global disease burden is caused by ten diseases or conditions: pneumonia (which 
accounts for 6% of the total DALYs), perinatal conditions, diarrheal diseases, HIV/AIDS, 
depression, heart disease, cerebrovascular disease, malaria, road traffic accidents, and tuberculosis, 
reported Currat during a presentation at IDRC in April.  
Health determinants  
In terms of health determinants, the top risk factors are malnutrition (which causes an estimated 
16% of the total disease burden), water/sanitation, unsafe sex, alcohol, indoor air pollution, 
tobacco, occupational hazards, hypertension, physical inactivity, illicit drugs, and outdoor air 
pollution, notes Currat.  
To increase research spending on the major diseases and health determinants, the Forum is 
pursuing three strategies: (i) hosting an annual meeting to review progress and define future 
actions to correct the 10/90 gap; (ii) supporting partnership initiatives in key health research areas; 
and (iii) supporting the development of priority setting methodologies.  
Annual meetings  
Since the Forum's inaugural meeting in June 1997, attendance at these annual events has increased 
from 120 to more than 800 participants last October (at the International Conference on Health 
Research in Bangkok). According to Currat, the Forum welcomes "any institution that's in a 
position to reduce the 10/90 gap including government policy makers, multilateral agencies, 
bilateral agencies, foundations, NGOs, women's organizations, research institutions, the private 
sector, and media."  
As a result of its discussions with partners, the Forum has launched seven strategic initiatives (with 
another three under development): the Alliance for Health Policy and Systems Research, 
Medicines for Malaria Venture, Public/Private Partnerships for Health, Global Tuberculosis 
Research Initiative, Cardiovascular Health in Developing Countries, Sexual Violence Against 
Women, and Child Health and Nutrition Research. "One of the characteristics of our initiatives is 
that the problem to be solved has to be beyond the capacity of any single institution," says Currat. 
"And, of course, we don't launch any initiative unless we have a very clear definition of the 
problem, the objectives, the strategies, the resources, the organization, the costs of financing, and 
the indicators of performance."  
Health systems  
He says the Alliance for Health Policy and Systems Research was launched because health systems 
affect so many diseases. "Why is pneumonia still the number one disease burden? Because health 
systems do not perform well. People don't have access to health care. And when they do have 
access, they are not always adequately treated, they get the wrong answers, the treatment is often 
too complicated, it is badly administered, or it creates drug resistance — so it contributes to the 
problem rather than the solution. Thus, the functioning of health systems is at the root of many 
problems we're facing."  
Another initiative, the Medicines for Malaria Venture (MMV), aims to accelerate the development 
of anti-malarial drugs — there is no new research currently being undertaken by the private sector, 
says Currat. MMV is a public-private partnership. During its first year of operation, the team 
reviewed 101 drug research proposals from both the public and private sector, from which the most 
promising five or six were selected. "With the US$15 million we have this year, we are going to 
both finance the continuation of this research and identify further projects to support," he explains. 
One stipulation is that any potential medicines must be affordable for developing countries.  
Priority setting  
The Forum's third strategy is to make a contribution in the field of priority setting methodologies. 
So far, it has developed a priority setting framework, which combines useful elements from 
existing methods. "There were no real priority setting methods before 1990," says Currat. Until 
then, "we never really worried whether we were investing in health research according to priorities 
or not." However, some factors are clearly more important than others when it comes to 
international health protection, he stresses.  
The framework poses five questions that aim to characterize the burden of different diseases, 
determine why the disease persists, assess the current level of knowledge about the disease, 
estimate the cost-effectiveness of future interventions, and tally the current resource flows devoted 
to research on the disease. For each question, framework users must indicate which of four 
intervention levels — individual, family, and community; health ministry, health research 
institutions, and health systems and services; sectors other than health; or central government — 
are most promising for further research.  
Best judgement  
"It's not a mechanical conclusion. Everyone has to apply his or her best judgement in order to use 
the framework," says Currat. For example, to reduce malnutrition among children, someone may 
argue that it's important to focus on the education of girls between the age of 12 and 16, "because 
two years from now they'll have their first child and five years from now they'll have three 
children." Another expert may argue that a malnutrition reduction strategy should focus on 
micronutrients, and involve research institutions and health ministries.  
In this way, the framework offers "a container for holding different ideas about how to attack a 
major health problem. People can disagree, and they can do different things. But at least there is a 
common denominator for this discussion," concludes Currat. To date, the Forum's approach to 
priority setting has been adopted by some WHO units, while research institutions in India, 
Tanzania, Pakistan, and Canada are examining the framework.  
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